CDK4 and lung carcinoma: Therefore, we propose that FBXO22 controls the cell cycle by regulating substrate protein levels, which we confirmed in the lung cancer cell line A549: overexpression of FBXO22 increased the expression of cyclin-dependent kinase 4 (CDK4) and promoted cell proliferation.